Pretherapy Nuclear Factor- B Status, Chemoradiation Resistance, and Metastatic Progression in Esophageal Carcinoma

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-06-0351
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Metastatic Esophageal Squamous Cell Carcinoma in the Kidney

Journal of Interdisciplinary Histopathology
2014English

Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy

Frontiers in Oncology
Cancer ResearchOncology
2013English

Clinical Biology of Esophageal Adenocarcinoma After Surgery Is Influenced by Nuclear Factor- B Expression

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2007English

The Prediction of Deterioration of Nutritional Status During Chemoradiation Therapy in Patients With Esophageal Cancer

Nutrition and Cancer
MedicineNutritionOncologyCancer ResearchDietetics
2018English

Expression of Insulin-Like Growth Factor Binding Protein-5 (IGFBP5) Reverses Cisplatin-Resistance in Esophageal Carcinoma

Cells
2018English

Inhibition of Nuclear Factor-κB Activity by Small Interfering RNA in Esophageal Squamous Cell Carcinoma Cell Lines

Oncology Reports
MedicineCancer ResearchOncology
2011English

Nickel Ion Inhibits Nuclear Factor-Kappa B Activity in Human Oral Squamous Cell Carcinoma

PLoS ONE
Multidisciplinary
2013English

Clinical Correlation of Nuclear Survivin in Esophageal Squamous Cell Carcinoma

Medical Oncology
MedicineCancer ResearchOncologyHematology
2012English

RUNX3 Reverses Cisplatin Resistance in Esophageal Squamous Cell Carcinoma via Suppression of the Protein Kinase B Pathway

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy